Estimating the Size of the HCV Infection Prevalence: A Modeling Approach Using the Incidence of Cases Reported to an Official Notification System

Bulletin of Mathematical Biology

Volumn 78, Issue 5, 2016, Pages 970-990

  Amaku, Marcos ^a   Burattini, Marcelo Nascimento ^a,b   Coutinho, Francisco Antonio Bezerra ^a   Lopez, Luis Fernandez ^a,c   Mesquita, Fabio ^d   Naveira, Marcelo Contardo Moscoso ^d   Pereira, Gerson Fernando Mendes ^d   Santos, Melina Érica ^d   Massad, Eduardo ^a,e  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d MINISTÉRIO DA SAÚDE   (Brazil)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Hepatitis C; Mathematical models; Notification system incidence; Prevalence

Indexed keywords

BRAZIL; DISEASE NOTIFICATION; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LIVER TRANSPLANTATION; MATHEMATICAL PHENOMENA; PREVALENCE; STATISTICAL MODEL;

BRAZIL; DISEASE NOTIFICATION; HEPATITIS C; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; MATHEMATICAL CONCEPTS; MODELS, STATISTICAL; PREVALENCE; WAITING LISTS;

EID: 84966652124     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-016-0170-4     Document Type: Article

References (27)

1. Ackerman Z, Ackerman E, Paltiel O (2000) Intrafamilial transmission of hepatitis C virus: a systematic review. J Viral Hepat 7(2):93–103
2. Amaku M, Coutinho FAB, Azevedo RS, Burattini MN, Lopez LF, Massad E (2003) Vaccination against rubella: analysis of the temporal evolution of the age-dependent force of infection and the effects of different contact patterns. Phys Rev E 67(5):051907
3. Burattini MN, Massad E, Rozman M, Azevedo RS, Carvalho HB (2000) Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison. Revista de Saúde Pública 34(5):431–436
4. Chaib E, de Oliveira MCF, Galvao FHF, Silva FD, D’Albuquerque LAC, Massad E (2010) Theoretical impact of an anti-HCV vaccine on the annual number of liver transplantation. Med Hypotheses 75(3):324–327
5. Chaib E, Figueira ERR, Brunheroto A, Gatti AP, Fernandes DV, D’Albuquerque LAC (2014) Does the patient selection with the MELD score improve short-term survival in liver transplantation? Arquivos Brasileiros de Cirurgia Digestiva 26(4):324–327
6. Chisari VF (2005) Unscramblinghepatitis C virus-host interactions. Nature 436:930–932
7. Cox AL (2015) Global control of hepatitis C virus. Science 349(6250):790–791
8. Crofts N, Thompson S, Kaldor J (1999) Epidemiology of the hepatitis C virus. Technical Report Series No. 3, Communicable Diseases Network Australia and New Zealand
9. Custer B, Sullivan S, Hazlet TK, Iloeje U, Veensti V (2004) Global epidemiology of hepatitis virus. J Clin Gastroenterol 38(10):S158–S168
10. Giannini C, Bréchot C (2003) Hepatitis C virus biology. Cell Death Differ 10:S27–S38
11. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61:S45–S57
12. Hill A, Cooke G (2014) Hepatitis C can be cured globally, but at what cost? Science 345(6193):141–142
13. Holtzman D (2014) Hepatitis C. Yellow Book Traveler’s Health, CDC, Chap 3:1–4. http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-to-travel/hepatitis-c. Accessed in 26th May 2015
14. Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology 36(5):S21–S29
15. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345(1):41–52
16. Laurence SP (2000) Advances in the treatment of hepatitis C. Adv Intern Med 45:65–105
17. Massad E, Rozman M, Azevedo RS, Silveira ASB, Takey K, Yamamoto YI, Strazza L, Ferreira MMC, Carvalho HB, Burattini MN (1999) Seroprevalence of HIV, HCV and syphilis in Brazilian Prisoners: preponderance of parenteral transmission. Eur J Epidemiol 15(5):439–445
18. Massad E, Coutinho FAB, Chaib E, Burattini MN (2009) Cost-effectiveness analysis of a hypothetical hepatitis C vaccine compared to antiviral therapy. Epidemiol Infect 137(2):241–249
19. Nakano T, Lau GMG, Lau GML, Sgiyama M, Mizokami M (2012) An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int 32(2):339–345
20. Reiche EM, Bonametti AM, Morimoto HK, Morimoto AA, Wiechemann SL, Matsuo T, Vissoci Reiche F, Vogler IH (2008) Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infected patients from a southern Brazilian population. Int J Mol Med 21:387–395
21. Romano CM, de Carvalho-Mello IMVG, Jamal LF, de Melo FL, Iamarino A, Motoki M, Pinho JRR, Holmes EC, Zanotto PMA, and the VGDN Consortium (2010) Social networks shape the transmission dynamics of hepatitis C virus. PLoS One 5(6):e11170. doi:10.1371/journal.pone.0011170
22. Rosen HR (2011) Chronic hepatitis C infection. N Engl J Med 364(25):2429–2438
23. Simmonds P (2013) The origin of hepatitis C virus. In: Bartenschlager R (ed) Hepatitis C virus: from molecular virology to antiviral therapy. Book Series: Current topics in microbiology and immunology, vol 369, pp 1–15
24. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5:558–567
25. Strazza L, Massad E, Azevedo RS, Carvalho HB (2007) Behavior associated with HIV and HCV infection in female prison inmates in Sao Paulo, Brazil. Cadernos de Saude Publica 23(1):197–205
26. Thein HH, Yi QL, Dore GJ, Krahn MD (2008) Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology 48(2):418–431
27. van den Hoek JAR, van Haastrescht JA, de Goudsmit J, Wolf F, Coutinho RA (1990) Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 162(4):823–826